Detalhe da pesquisa
1.
Consensus gene modules strategy identifies candidate blood-based biomarkers for primary Sjögren's disease.
Clin Immunol
; 264: 110241, 2024 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38735508
2.
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years.
Ann Rheum Dis
; 2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38782549
3.
Examining the biological pathways underlying clinical heterogeneity in Sjogren's syndrome: proteomic and network analysis.
Ann Rheum Dis
; 83(1): 88-95, 2024 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37657927
4.
Counteracting tryptophan metabolism alterations as a new therapeutic strategy for rheumatoid arthritis.
Ann Rheum Dis
; 83(3): 312-323, 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38049981
5.
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2023.
Ann Rheum Dis
; 83(4): 409-416, 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38123338
6.
Chronic stimulation with SARS-CoV-2 spike protein does not trigger autoimmunity.
Clin Immunol
; 248: 109264, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36804225
7.
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2022.
Ann Rheum Dis
; 82(5): 594-598, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36702529
8.
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update.
Ann Rheum Dis
; 82(1): 3-18, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36357155
9.
Identification of new candidate drugs for primary Sjögren's syndrome using a drug repurposing transcriptomic approach.
Rheumatology (Oxford)
; 62(11): 3715-3723, 2023 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36869684
10.
Integrated safety analysis of filgotinib treatment for rheumatoid arthritis in patients from Japan over a median of 1.5 years.
Mod Rheumatol
; 33(1): 64-72, 2023 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35365828
11.
Integrated safety analysis of filgotinib in patients with moderately to severely active rheumatoid arthritis receiving treatment over a median of 1.6 years.
Ann Rheum Dis
; 81(2): 184-192, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34740884
12.
Development and preliminary validation of the Sjögren's Tool for Assessing Response (STAR): a consensual composite score for assessing treatment effect in primary Sjögren's syndrome.
Ann Rheum Dis
; 81(7): 979-989, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35393271
13.
Risk of diverticulitis and gastrointestinal perforation in rheumatoid arthritis treated with tocilizumab compared to rituximab or abatacept.
Rheumatology (Oxford)
; 61(3): 953-962, 2022 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33993216
14.
Significance of Sjögren's syndrome and anti-cN1A antibody in myositis patients.
Rheumatology (Oxford)
; 61(2): 756-763, 2022 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33974078
15.
Sjögren's syndrome and other rare and complex connective tissue diseases: an intriguing liaison.
Clin Exp Rheumatol
; 40 Suppl 134(5): 103-112, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35349420
16.
Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy: A Randomized Clinical Trial.
JAMA
; 328(11): 1053-1062, 2022 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36125471
17.
Efficacy and safety of filgotinib in Japanese patients with refractory rheumatoid arthritis: Subgroup analyses of a global phase 3 study (FINCH 2).
Mod Rheumatol
; 32(1): 59-67, 2022 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33274687
18.
Efficacy and safety of abatacept in active primary Sjögren's syndrome: results of a phase III, randomised, placebo-controlled trial.
Ann Rheum Dis
; 80(3): 339-348, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33168545
19.
EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors.
Ann Rheum Dis
; 80(1): 36-48, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32327425
20.
Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial.
Ann Rheum Dis
; 80(3): 329-338, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33208345